Related Experiment Video
Updated: Mar 15, 2026
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
Published on: August 24, 2015
Current Status of Platelet Transfusion in Pediatric Patients
Steven R Sloan1, Robert I Parker2
1Department of Laboratory Medicine and Joint Program of Transfusion Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA..
Insights
Pediatric platelet transfusions are mainly for children with cancer, undergoing stem cell transplants, or with bleeding after surgery. More research is needed to determine best practices for these young patients.
Area of Science:
- Pediatric Hematology
- Transfusion Medicine
Background:
- Platelet transfusions in pediatric patients are common outside the neonatal period.
- Indications include thrombocytopenia due to malignancy, hematopoietic progenitor cell transplant, and bleeding from surgery, particularly cardiac surgery.
Purpose of the Study:
- To highlight the current indications for platelet transfusions in pediatric patients.
- To emphasize the need for pediatric-specific research in transfusion practices.
- To identify specific patient populations requiring further investigation.
Main Methods:
- Review of current pediatric transfusion practices.
- Comparison with adult transfusion protocols.
- Identification of knowledge gaps in pediatric transfusion research.
Main Results:
- Pediatric transfusion practices largely mirror adult protocols due to a lack of pediatric-specific studies.
- Key patient groups needing focused research include oncology, hematopoietic progenitor cell transplant, and cardiac surgery patients.
Conclusions:
- Current pediatric platelet transfusion protocols are primarily based on adult data.
- There is a critical need for dedicated pediatric research to establish evidence-based guidelines.
- Optimizing indications and dosages for specific pediatric populations is essential.
Abstract:
Outside the neonatal period, most platelets that are transfused to pediatric patients are given to those who are thrombocytopenic secondary to malignancy and associated therapy and/or hematopoietic progenitor cell transplant, or to those with significant bleeding associated with surgery, especially cardiac surgery. Indications for platelet transfusion, doses, and other practices for children largely mimic adult platelet transfusion protocols because there are few pediatric-specific studies in this area. Pediatric platelet transfusion practices would benefit from focused pediatric research. The appropriate indications and doses for platelet transfusions in oncology, hematopoietic progenitor cell transplant, and cardiac surgery patients need to be determined.
Related Concept Videos
02:45Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
01:18Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...